![]() |
|
|
Vol. 283, Issue 1, 286-292, 1997
Klinik III für Innere Medizin der Universität zu
Köln, 50924 Köln, Germany
The present study investigated the functional role of the sarcoplasmic
reticulum Ca++-ATPase in contraction and relaxation,
intracellular Ca++-transients, as well as on the
force-frequency relationship in human myocardium. The
Ca++-ATPase activity of membrane vesicles isolated from
sarcoplasmic reticulum (SR) obtained from nonfailing donor hearts
(n = 7) was measured in the presence of
cyclopiazonic acid (CPA, 0-30 µM), a highly specific inhibitor of
the Ca++-ATPase of the SR (SERCA). The effects of CPA on
parameters of contraction and relaxation, force-frequency relationship
and [Ca++]i transients (with fura-2) were
studied on isolated left ventricular muscle strips from human
nonfailing myocardium. CPA concentration-dependently inhibited SERCA
activity of isolated SR vesicles. In the presence of CPA (30 µM) the
former positive force-frequency relationship in human left ventricular
nonfailing myocardium became negative. Especially at high frequencies
of stimulation, CPA decreased developed tension, peak rate of tension
rise and systolic fura-2-light emission, whereas time to peak tension,
time to peak [Ca++]i, time to 95%
relaxation, diastolic tension and diastolic Ca++ levels
were increased. Peak rate of tension decay and time to half-relaxation
and half-decay of [Ca++]i were not altered
significantly after treatment with CPA. These findings provide evidence
that the SERCA plays a functional role in the frequency-dependent
increase in force of contraction in human myocardium. Because an
impaired function of the SERCA is predominantly followed by alterations
of inotropic and to a lesser degree of lusitropic function, other
important factors to lower [Ca++]i and
influence relaxation may be present in human myocardium to compensate
for the reduced SERCA activity, e.g.,
Na+-Ca++ exchanger.
This article has been cited by other articles:
![]() |
N. S. Ghais, Y. Zhang, A. A. Grace, and C. L.-H. Huang Arrhythmogenic actions of the Ca2+ channel agonist FPL-64716 in Langendorff-perfused murine hearts Exp Physiol, February 1, 2009; 94(2): 240 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Kaye, A. Preovolos, T. Marshall, M. Byrne, M. Hoshijima, R. Hajjar, J. A. Mariani, S. Pepe, K. R. Chien, and J. M. Power Percutaneous Cardiac Recirculation-Mediated Gene Transfer of an Inhibitory Phospholamban Peptide Reverses Advanced Heart Failure in Large Animals J. Am. Coll. Cardiol., July 17, 2007; 50(3): 253 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pillekamp, M. Reppel, O. Rubenchyk, K. Pfannkuche, M. Matzkies, W. Bloch, N. Sreeram, K. Brockmeier, and J. Hescheler Force Measurements of Human Embryonic Stem Cell-Derived Cardiomyocytes in an In Vitro Transplantation Model Stem Cells, January 1, 2007; 25(1): 174 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G Taylor, L. D Parilak, M. M LeWinter, and H. J Knot Quantification of the rat left ventricle force and Ca2+-frequency relationships: similarities to dog and human Cardiovasc Res, January 1, 2004; 61(1): 77 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F Frank, B. Bolck, E. Erdmann, and R. H.G Schwinger Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation Cardiovasc Res, January 1, 2003; 57(1): 20 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Brixius, S. Reicke, and R. H. G. Schwinger Beneficial effects of the Ca2+ sensitizer levosimendan in human myocardium Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H131 - H137. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Herr, N. Smyth, S. Ullrich, F. Yun, P. Sasse, J. Hescheler, B. Fleischmann, K. Lasek, K. Brixius, R. H. G. Schwinger, et al. Loss of Annexin A7 Leads to Alterations in Frequency-Induced Shortening of Isolated Murine Cardiomyocytes Mol. Cell. Biol., July 1, 2001; 21(13): 4119 - 4128. [Abstract] [Full Text] [PDF] |
||||